Physician

Milene Kennedy Crispin, M.D.

According to 2025 Medicare claims, Milene Crispin, M.D. (NPI: 1811253040) practices dermatology in the Salinas, CA market, with the plurality of this provider's patient population coming from Monterey, CA. This provider's primary affiliated billing organization is CSI MEDICAL GROUP (NPI: 1871909804; TIN: 471108040) and primary practice location at 93940-6509.

Crispin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,734 traditional Medicare patients, billed 7,289 HCPCS/CPT codes, and received $1,120,787 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 1,043 prescription claims across 442 beneficiaries totaling $239,551 in drug costs, led by Dupixent Syringe (Dupilumab). Open Payments data shows 10 records totaling $247. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $68,670 to $1,120,787. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $9,090 and ending at $239,551. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$560K$1.1M2017 Medicare payment: $68,670 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $454,372 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $682,455 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $820,750 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $884,205 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $914,956 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,021,286 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,120,787 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017255835$68,670
20189643,903$454,372
20191,0305,376$682,455
20201,2305,597$820,750
20211,3545,975$884,205
20221,6257,347$914,956
20231,8278,424$1,021,286
20241,7347,289$1,120,787

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$261K$522K2016 Drug cost: $9,090 (USD; Tot_Drug_Cst)2017 Drug cost: $14,899 (USD; Tot_Drug_Cst)2018 Drug cost: $122,714 (USD; Tot_Drug_Cst)2019 Drug cost: $375,226 (USD; Tot_Drug_Cst)2020 Drug cost: $522,054 (USD; Tot_Drug_Cst)2021 Drug cost: $366,024 (USD; Tot_Drug_Cst)2022 Drug cost: $412,452 (USD; Tot_Drug_Cst)2023 Drug cost: $184,154 (USD; Tot_Drug_Cst)2024 Drug cost: $239,551 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/R21$9,090
201785164$14,899
2018334783$122,714
2019347831$375,226
2020351867$522,054
20214341,005$366,024
20224311,000$412,452
2023432950$184,154
20244421,043$239,551

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks435527$527
17312Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks271388$358
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more8521,139$97
11102Biopsy of related skin growth, first growth603803$77
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more8841,154$65

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent SyringeDupilumab12336$45,445
FluorouracilFluorouracil1053,093$7,735
TretinoinTretinoin351,755$2,472
FluocinonideFluocinonide351,425$1,528
Triamcinolone AcetonideTriamcinolone Acetonide1667,520$1,504

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.10$247Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Milene Kennedy Crispin, M.D.?

Tedicare shows public-source Medicare data for Milene Kennedy Crispin, M.D. (NPI 1811253040), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Milene Kennedy Crispin, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Milene Kennedy Crispin, M.D.?

Milene Kennedy Crispin, M.D. is linked to CSI MEDICAL GROUP (billing NPI 1871909804) in the available physician profile data.

Does Milene Kennedy Crispin, M.D. have Open Payments data?

Milene Kennedy Crispin, M.D. has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.